OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

JOHNSON + JOHNSON DL 1/  US4781601046  /

Düsseldorf
1/23/2025  7:30:53 PM Chg. +2.30 Volume Bid8:04:56 PM Ask8:04:56 PM Market Capitalization Dividend Y. P/E Ratio
140.62EUR +1.66% 0
Turnover: 0.00		 -Bid Size: - -Ask Size: - 341.11 bill.EUR - -
TeleTrader 1/22 J&J's Q4 sales beat estimates, up 5.3% to $22.5B
TeleTrader 1/20 Earnings preview: Netflix, J&J, easyJet and more
TeleTrader 1/13 J&J to buy Intra-Cellular Therapies in $14.6B deal
TeleTrader 1/2 J&J announces dividend for Q1 2025
TeleTrader 10/15/2024 J&J's Q3 sales rise by 5.2% to $22.5B
TeleTrader 10/1/2024 J&J: Over $2B to be put into new facility in North Carolina
TeleTrader 9/10/2024 D. S. Davis retires as director of Johnson & Johnson
TeleTrader 8/20/2024 Johnson & Johnson to buy V-Wave for up to $1.7B
GlobeNewswire 8/14/2024 BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
TeleTrader 7/17/2024 J&J's Q2 sales up by 4.3% to $22.4 billion
GlobeNewswire 5/28/2024 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
TeleTrader 5/1/2024 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 4/17/2024 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 4/10/2024 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 4/5/2024 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 3/26/2024 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 3/15/2024 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 3/6/2024 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 1/27/2024 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 1/24/2024 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 1/23/2024 J&J to pay $700M in talc powder probe settlement
TeleTrader 1/23/2024 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 1/23/2024 Johnson & Johnson Q4 earnings preview
TeleTrader 1/22/2024 Earnings preview: Tesla takes center stage
TeleTrader 1/8/2024 J&J to buy biotech company Ambrx for $2B